Dr. Hana Golan, MD

At a glance

Core facts about the doctor and the hospital, as provided by the hospital.

About

• TEACHING• Coordinator of the Hematology course for medical students, Sackler Faculty of Medicine at Tel Aviv University, Israel, 2009-2011• Pediatric Hematology oncology lectures for medical students and nurses,
• 1996Present.• Tutor in charge of medical students, 1991-1992PROJECTS·        Director of the computerized program of the inpatient and outpatient computerized medical record·         Establishment of   computerized chemotherapy protocols and patient’s database, 1999 – ‏2014.CLINICAL TRIALS EXPERIENCE• Principle investigator of the High Risk Neuroblastoma 1.7 ESIOP protocol, Sheba medical center, 2002 – present.• Principle investigator of the “Phase I/II, 2-part, Multi Center, Single arm, Open-Label Study, to determine the Safety, Tolerability and Pharmacokinetics of oral Dabrafenib in Children and Adolescent Subjects with Advanced BRAF V-600 Mutation Positive Solid Tumors. 2015-2016• Principle investigator of the “Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder”  2013-2015·         National coordinator of the High Risk Neuroblastoma 1 ESIOP protocol, 2002 – 2005·  Active involvement in several basic research programs including:• Identification and isolation of cancer stem cells in pediatric malignancies in order to identify targetable markers (2 papers are currently in the processes of submission)• The role of cannabinoids as anti-cancer drug in pediatric malignanciesPositions• Deputy Director of the Pediatric Hemato-Oncology and BMT Division• Head of the Pediatric Hemato-Oncology Day Care Service• Professional memberships: Israel Medical Association, Israel Society of Pediatric Hematology Oncology, Israel Society of Hematology and Blood Transfusions

About this profile